Deep brain stimulation lead removal in Tourette syndrome.


Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
08 2020
Historique:
received: 10 04 2020
revised: 19 06 2020
accepted: 22 06 2020
pubmed: 28 7 2020
medline: 7 9 2021
entrez: 27 7 2020
Statut: ppublish

Résumé

Tourette syndrome (TS) is a complex neuropsychiatric disorder. A small percentage of individuals with TS can experience persistent severe, refractory, and impairing tics. Deep brain stimulation (DBS) has been increasingly used for symptom management, especially in these settings. In this article, we aim to evaluate the rate and the reasons for removal of DBS hardware in TS patients. Data was analyzed from patients enrolled in the Tourette Association of America's International Tourette Syndrome Registry and Database. Fifteen of 269 (5.6%) patients required removal of their DBS systems. The mean age at explantation was 33.8 years. In these cases we observed a rate of 1.9 explantations per year of follow up from implantation. None of the removals took place in the immediate post-operative period. Infection was the most common cause (46.7%). Only one patient received explantation for tic resolution. There were no significant associations between explantation and the presence of specific psychiatric comorbidities, including OCD, depression, anxiety, or ADHD. The rate of removal of 5.6% was lower than the previously reported rate in the TS DBS literature. Infections accounted for nearly half of the TS DBS explantations in this cohort. There was no relationship to psychiatric comorbidities.

Identifiants

pubmed: 32712563
pii: S1353-8020(20)30202-9
doi: 10.1016/j.parkreldis.2020.06.025
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

89-93

Subventions

Organisme : NINR NIH HHS
ID : R01 NR014852
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS096008
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Wissam Deeb (W)

Norman Fixel Institute for Neurological Disease, Department of Neurology, University of Florida, Gainesville, FL, USA. Electronic address: wissam.deeb@neurology.ufl.edu.

Albert F G Leentjens (AFG)

Department of Psychiatry, Maastricht University Medical Center, Maastricht, the Netherlands.

Alon Y Mogilner (AY)

NYU Langone Health, New York University School of Medicine, New York, NY, USA.

Domenico Servello (D)

Tourette Clinic and Functional Neurosurgical Department, IRCCS Galeazzi Hospital, Milano, Italy.

Fangang Meng (F)

Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Jianguo Zhang (J)

Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Tommaso Francesco Galbiati (TF)

Tourette Clinic and Functional Neurosurgical Department, IRCCS Galeazzi Hospital, Milano, Italy.

Michael S Okun (MS)

Norman Fixel Institute for Neurological Disease, Department of Neurology, University of Florida, Gainesville, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH